Amplify Weight Loss Drug ... (THNR)
NYSEArca: THNR
· リアルタイム株価 · USD
26.50
-0.11 (-0.41%)
終値時点： Aug 12, 2026, 3:49 PM
Amplify Weight Loss Drug & Treatment ETF (THNR) ETF Price, Holdings & Analysis
-0.41% (1D)
| 買気配 | 26.54 |
| 時価総額 | n/a |
| 純資産総額 | 5.07M |
| 基準価額 | 26.58 |
| ベータ | n/a |
| EPS（過去12か月） | n/a |
| PER（過去12か月） | 19.19 |
| 発行済口数 | n/a |
| 設定日 | May 20, 2024 |
| 売気配 | 0 |
| 出来高 | 3,226 |
| 平均出来高（20日） | 1,929 |
| 始値 | 26.50 |
| 前日終値 | 26.61 |
| 日中値幅 | 26.50 - 26.59 |
| 52週の値幅 | 22.33 - 27.28 |
| 組入銘柄 | n/a |
| 経費率 | 0.59% |
THNRについて
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies expected to economically benefit from weight loss drug development. The index includes pharmaceutical manufacturers, manufacturers of combination therapies and telehealth providers who provide access to Amylin agonists and analogs or GLP-1 agonists and analogs, including dual GLP-1 agonists and analogs. The fund is non-diversified.
上位10銘柄 純資産の61.60%
| 名称 | シンボル | 構成比 |
|---|---|---|
| Novo Nordisk As Adr | NVO | 9.70% |
| Eli Lilly And Co | LLY | 8.92% |
| Regeneron Pharmaceut... | REGN | 6.03% |
| Cspc Pharmaceutical ... | 1093.HK | 5.52% |
| Arrowhead Pharmaceut... | ARWR | 5.34% |
| Innovent Biologics I... | 1801.HK | 5.34% |
| Amgen Inc | AMGN | 5.25% |
| Abbvie Inc | ABBV | 5.24% |
| Roche Holding Ag Ord... | ROP.SW | 5.20% |
| Merck & Co Inc | MRK | 5.06% |
2ページ中1ページ